UnitedHealth Group

Jan 19, 2025

UnitedHealth Group (NYSE:UNH) Given Overweight Rating at Cantor Fitzgerald Posted by MarketBeat News on Jan 19th, 2025 UnitedHealth Group ( NYSE:UNH – Get Free Report )‘s stock had its “overweight” rating reissued by analysts at Cantor Fitzgerald in a research note issued on Friday, Benzinga reports. They currently have a $700.00 price target on the healthcare conglomerate’s stock. Cantor Fitzgerald’s price objective points to a potential upside of 37.25% from the stock’s current price. A number of other research firms also recently commented on UNH. Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Barclays boosted their price target on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Truist Financial cut their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Bank of America cut their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $627.74. Get UnitedHealth Group alerts: Shares of NYSE:UNH opened at $510.03 on Friday. The business’s 50 day simple moving average is $549.37 and its 200-day simple moving average is $562.73. The firm has a market capitalization of $469.37 billion, a price-to-earnings ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group ( NYSE:UNH – Get Free Report ) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the company posted $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group will post 27.6 earnings per share for the current fiscal year. Institutional Investors Weigh In On UnitedHealth Group Several institutional investors and hedge funds have recently bought and sold shares of the business. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the last quarter. West Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $32,000. Quarry LP boosted its stake in UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $37,000. Institutional investors and hedge funds own 87.86% of the company’s stock. UnitedHealth Group Company Profile